NEW YORK, June 15, 2017 /PRNewswire/ --
On Wednesday, June 14, 2017, the NASDAQ Compositeended the trading session at 6,194.89, down 0.41%; the Dow Jones Industrial Average edged 0.22% higher, to finish at 21,374.56; and the S&P 500 closed at 2,437.92, marginally dropping 0.10%. US markets saw a mixed session as 4 sectors closed in green,
On Wednesday, shares in Draper, Utah headquartered HealthEquity Inc. recorded a trading volume of 758,939 shares, which was above their three months average volume of 557,240 shares. The stock ended at $51.57, declining 0.79% from the last trading session. The Company's shares have gained 13.02% in the last one month, 12.40% over the previous three months, and 27.27% on an YTD basis. The stock is trading above its 50-day and 200-day moving averages by 12.93% and 23.80%, respectively. Furthermore, shares of HealthEquity, which provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the US, have a Relative Strength Index (RSI) of 63.72.
On June 07th, 2017, research firm Chardan Capital Markets reiterated its 'Buy' rating on the Company's stock with an increase of the target price from $53 a share to $57 a share. Sign up and read the free research report on HQY at:
New York headquartered Medidata Solutions Inc.'s stock finished yesterday's session 1.30% higher at $73.93 with a total trading volume of 370,584 shares. The Company's shares have gained 6.65% in the last one month, 27.47% over the previous three months, and 48.84% on an YTD basis. The stock is trading above its 50-day and 200-day moving averages by 9.11% and 29.86%, respectively. Furthermore, shares of Medidata Solutions, which provides cloud-based solutions for life sciences worldwide, have an RSI of 56.28.
On June 06th, 2017, research firm Bank of America/ Merrill initiated a 'Buy' rating on the Company's stock, with a target price of $85 per share. The complimentary research report on MDSO can be downloaded at:
At the close of trading on Wednesday, shares in Charlotte, North Carolina headquartered Premier Inc. saw a slight decline of 0.11%, ending the day at $35.29. The stock recorded a trading volume of 345,173 shares. The Company's shares have advanced 1.61% in the last one month, 12.75% in the previous three months, and 16.24% since the start of this year. The stock is trading 4.08% and 10.70% above its 50-day and 200-day moving averages, respectively. Moreover, shares of Premier, which together with its subsidiaries, operates as a healthcare improvement company in the US, have an RSI of 61.28. Register for free on DailyStockTracker.com and access the latest report on PINC at:
Arlington, Virginia headquartered Evolent Health Inc.'s shares ended the day 1.18% higher at $25.75 with a total trading volume of 968,484 shares. The stock has gained 3.21% in the last month, 21.18% over the previous three months, and 73.99% on an YTD basis. The Company's shares are trading 9.31% above their 50-day moving average and 22.70% above their 200-day moving average. Additionally, shares of Evolent Health, which through its subsidiary, Evolent Health LLC, provides healthcare delivery and payment solutions in the US, have an RSI of 56.84.
On June 02nd, 2017, research firm Robert W. Baird initiated an 'Outperform' rating on the Company's stock, with a target price of $30 per share. Get free access to your research report on EVH at:
Daily Stock Tracker:
Daily Stock Tracker (DST) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. DST has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
DST has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email email@example.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by DST. DST is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
DST, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. DST, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, DST, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither DST nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
CONTACT For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at: Email: firstname.lastname@example.org Phone number: (207)331-3313 Office Address: 377 Rivonia Boulevard, Rivonia, South Africa CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Chelmsford Park SA
Subscribe to our Free Newsletters!
Some drugs or therapeutic agents cause undesirable reactions in lungs, known as drug-induced ...
Sleep disorders are collectively known as ''Somnipathy.'' There are over 70 different medically ...
Unintended pregnancies are very common these days, and so one in about four pregnant women go for ...View All